Literature DB >> 9546701

Bone loss in children with idiopathic hypercalciuria.

V García-Nieto, J F Navarro, C Ferrández.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9546701     DOI： 10.1159/000044950

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  6 in total

Review 1.  Bone disease and hypercalciuria in children.

Authors:  Joseph E Zerwekh
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

Review 2.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

3.  Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Marcelo Ferraz Oliveira Souto; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

4.  Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria.

Authors:  Augusto C S Santos; Eleonora M Lima; Maria Goretti M G Penido; Katia D Silveira; Mauro M Teixeira; Eduardo A Oliveira; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-01-07       Impact factor: 3.714

5.  Longitudinal study of bone mineral density in children with idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares; Mariana Campos Linhares; Ana Carolina Silva Barbosa; Maarmed Cunha
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

6.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.